TRENTON, N.J. – A Democrat proposal giving a government-created board the ability to control prescription drug prices in New Jersey will not help patients, but will destroy the state’s acclaimed life sciences industry, says Assemblyman Christopher DePhillips. “New Jersey, which is home to 14 of the world’s 20 largest...
Read More
TRENTON, N.J. – Creating a government-run board to control prescription drug prices in the medicine chest of the world, aka New Jersey, is bad for business and innovation, say Republicans. WATCH: Can Bureaucrats Really Lower Drug Prices?Reina Smrdelj, a legislative analyst at the Assembly Republican Office, reveals the potential...
MIDLAND PARK, N.J. – Assemblyman Chris DePhillips decided to introduce a pension divestment bill earlier this week after hearing complaints from leaders within the New Jersey pharmaceutical industry. “The outbreak has really become a wake-up call for the state and industry,” said DePhillips (R-Bergen). “New Jersey is supposed to...